These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32157115)

  • 1. Chemokine releasing particle implants for trapping circulating prostate cancer cells.
    Huang Y; Hakamivala A; Li S; Nair A; Saxena R; Hsieh JT; Tang L
    Sci Rep; 2020 Mar; 10(1):4433. PubMed ID: 32157115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
    Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
    Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.
    Hsu JW; Yasmin-Karim S; King MR; Wojciechowski JC; Mickelsen D; Blair ML; Ting HJ; Ma WL; Lee YF
    Am J Pathol; 2011 Feb; 178(2):872-80. PubMed ID: 21281819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.
    Yasmin-Karim S; King MR; Messing EM; Lee YF
    Oncotarget; 2014 Dec; 5(23):12097-110. PubMed ID: 25301730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
    Ieranò C; D'Alterio C; Giarra S; Napolitano M; Rea G; Portella L; Santagata A; Trotta AM; Barbieri A; Campani V; Luciano A; Arra C; Anniciello AM; Botti G; Mayol L; De Rosa G; Pacelli R; Scala S
    Cell Death Dis; 2019 Jul; 10(8):562. PubMed ID: 31332163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
    Sun YX; Pedersen EA; Shiozawa Y; Havens AM; Jung Y; Wang J; Pienta KJ; Taichman RS
    Clin Exp Metastasis; 2008; 25(7):765-76. PubMed ID: 18563594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.
    Macoska JA; Begley LA; Dunn RL; Siddiqui J; Wei JT; Sarma AV
    Prostate; 2008 Mar; 68(4):442-52. PubMed ID: 18196514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
    Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C
    Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of 3D Lymph Node Mimetic for Studying Prostate Cancer Metastasis.
    Hakamivala A; Huang Y; Chang YF; Pan Z; Nair A; Hsieh JT; Tang L
    Adv Biosyst; 2019 Sep; 3(9):e1900019. PubMed ID: 32648652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The origin of prostate metastases: emerging insights.
    Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
    Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.
    Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J
    J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
    Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
    Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
    Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
    PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.
    Wang J; Shiozawa Y; Wang J; Wang Y; Jung Y; Pienta KJ; Mehra R; Loberg R; Taichman RS
    J Biol Chem; 2008 Feb; 283(7):4283-94. PubMed ID: 18057003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.
    Shiozawa Y; McGee S; Pienta MJ; McGregor N; Jung Y; Yumoto K; Wang J; Berry JE; Pienta KJ; Taichman RS
    J Cell Biochem; 2013 Nov; 114(11):2471-8. PubMed ID: 23696192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumor cells and dormancy in prostate cancer metastasis.
    van der Toom EE; Verdone JE; Pienta KJ
    Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1, CXCR4 and VEGF.
    Ding G; Wang L; Xu H; Xu Z; Feng C; Ding Q; Fang Z; Wu Z; Jiang H; Xu J; Gao P
    Gen Physiol Biophys; 2013 Jun; 32(2):245-50. PubMed ID: 23682021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.
    Shanmugam MK; Manu KA; Ong TH; Ramachandran L; Surana R; Bist P; Lim LH; Kumar AP; Hui KM; Sethi G
    Int J Cancer; 2011 Oct; 129(7):1552-63. PubMed ID: 21480220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.